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The role of oxytocin receptor gene (OXTR)
DNA methylation (DNAm) in human social
and emotional functioning: a systematic
narrative review
Catherine Maud1* , Joanne Ryan2,3,4, Jennifer E. McIntosh1,2 and Craig A. Olsson1,2,3
Abstract
Background: The neuropeptide Oxytocin (OXT) plays a central role in birthing, mother-infant bonding and a broad
range of related social behaviours in mammals. More recently, interest has extended to epigenetic programming of
genes involved in oxytocinergic neurotransmission. This review brings together early findings in a rapidly
developing field of research, examining relationships between DNA methylation (DNAm) of the Oxytocin Receptor
Gene (OXTR) and social and emotional behaviour in human populations.
Method: A systematic search across Web of Knowledge/Science, Scopus, Medline and EMBASE captured all
published studies prior to June 2017 examining the association between OXTR DNAm and human social and
emotional outcomes. Search terms included ‘oxytocin gene’ or ‘oxytocin receptor gene’ and ‘epigenetics’ or ‘DNA
methylation’. Any article with a focus on social and emotional functioning was then identified from this set by
manual review.
Results: Nineteen studies met eligibility criteria. There was considerable heterogeneity of study populations, tissue
samples, instrumentation, measurement, and OXTR site foci. Only three studies examined functional consequences
of OXTR DNAm on gene expression and protein synthesis. Increases in OXTR DNAm were associated with callous-
unemotional traits in youth, social cognitive deficits in Autistic Spectrum Disorder (ASD), rigid thinking in anorexia
nervosa, affect regulation problems, and problems with facial and emotional recognition. In contrast, reductions in
DNAm were associated with perinatal stress, postnatal depression, social anxiety and autism in children.
Conclusions: Consistent with an emerging field of inquiry, there is not yet sufficient evidence to draw conclusions
about the role of OXTR DNAm in human social and emotional behaviour. However, taken together, findings point
to increased OXTR DNAm in general impairments in social, cognitive and emotional functioning, and decreased
OXTR DNAm in specific patterns of impairment related to mood and anxiety disorders (but not in all). Future
progress in this field would be enhanced by adequately powered designs, greater phenotypic precision, and
methodological improvements including longitudinal studies with multiple time-points to facilitate causal inference.
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Background
Oxytocin (OXT) is a neuropeptide and hormone impli-
cated in prosocial human social and emotional function-
ing [1]. OXT has been long known for its key role in
child birth and postpartum lactation, including changes
in infant gut hormones [2]. OXT plays a crucial role in
enhancing bonding and moderating the stress response.
Mothers’ neuroendocrine response to their baby’s cry, as
measured by functional neuroimaging (fMRI), has shown
to differ between vaginal and caesarean births, with
higher OXT levels linked to enhanced empathy and ma-
ternal arousal [3]. Mothers with higher plasma OXT
levels during early pregnancy have been shown to be
more responsive to their baby after birth, including
higher levels of gaze towards their infant’s face, positive
affect and affectionate touch [4].
Postpartum, the sucking stimulus by newborns in-
creases OXT release in the mother and thus decreases
plasma levels of stress hormones (ACTH and cortisol)
[5]. The physiological consequences of disrupted OXT
release are thus significant during the perinatal period,
however, there is also mounting evidence that disrupted
OXT availability could be related to a broad range of so-
cial behaviours, including childhood autistic spectrum
disorders (ASD) [6], attachment bonds in infancy [7]
and mood disorders and response to stress in women
[8].
This has led to the development of OXT treatments
including using nasal OXT to increase attachment se-
curity in healthy males with an insecure attachment pat-
tern [9] and improved social engagement between
fathers and their infants [10]. Further, intranasal OXT
increased trust and willingness to accept social risks
amongst healthy volunteers involved in an experimental
game [11], as well as the reduction of the short-term
stress response demonstrated by reduced cortisol release
[12]. In patients with Autistic spectrum disorder (ASD),
intranasal OXT has been shown to provide some im-
provements in adult social cognition [6] and youth emo-
tional recognition [13].
fMRI studies have shown that during a visual stress
task, intranasal OXT administration is associated with
reduced activation in the amygdala, which plays a key
role in emotion and social behaviour regulation [14].
Furthermore, central OXT has both anxiolytic and anti-
depressant effects which have been associated with im-
proved emotional behaviours and mental health [15].
This has led to the suggestion that OXT may be an im-
portant biomarker of stress exposures [16]. OXT plasma
concentrations also correlate with cerebrospinal concen-
trations and with childhood anxiety [17]. Disrupted per-
ipheral OXT release has been found in non-perinatal
women with depression during stress related tasks [8]
and with specific types of relationship stress in women
[18]. Taken together, these findings suggest an important
role for OXT in human social and emotional functioning.
Neurobiologically, OXT is synthesized by the OXT
gene in magnocellular neurons in the paraventricular
and supraoptic nuclei of the hypothalamus. OXT is then
transported along axonal projections to the posterior
lobe of the pituitary, where it is stored in secretory vesi-
cles before being released into the peripheral blood. In
addition, dendritic release of OXT occurs into the extra-
cellular space with diffusion through the brain. Smaller
parvocellular neurons in the paraventricular nucleus also
produce OXT and project directly to other regions in
the brain involved in human social and emotional func-
tioning including the amygdala, hippocampus, striatum,
suprachiasmatic nucleus, bed nucleus of stria terminalis
and brainstem - where they act as neuromodulators or
neurotransmitters and thereby influence neurotransmis-
sion in these areas [19].
Oxytocin receptors are synthesised by the Oxytocin
Receptor (OXTR) gene, which expresses both centrally
in the brain and within peripheral organs. In this way,
OXT has both peripheral and central functions. OXTR is
located on human chromosome 3p25.3 [20, 21]. The
OXTR gene spans 17 kilobytes (kb) and contains 3 in-
trons and 4 exons. Exons 1 and 2 correspond to
non-coding regions while exons 3 and 4 encode the
amino acids of the oxytocin receptor (Fig. 2). The oxyto-
cin receptor is a 389-amino acid G-protein coupled
transmembrane receptor, enabling the activation of a
number of different intracellular secondary messengers
facilitating the oxytocin pathway [22].
Genetic variants, including single nucleotide polymor-
phisms (SNPs), in the OXTR have been shown to inde-
pendently influence gene expression and been associated
with human emotional responsiveness and social behav-
iour [23]. Two SNPs rs2254298 and rs53576 have been
most investigated regarding the OXTR (Intron 3) (Fig.
2). Rs2254298 (G > A) has also been associated with aut-
istic spectrum disorder (ASD) [24], depressed women
and their families [25] and with smaller bilateral amyg-
dala volumes and greater grey matter volumes in a brain
imaging study [26], while rs237887 has been associated
with human social recognition skills [27]. Rs53576 (A >
G) has been associated with reduced positivity [28], re-
duced empathy [29] and decreased parental sensitivity
[30] while rs1042778 has been associated with reduced
parenting sensitivity [31] and rs237915 has been associ-
ated with brain responsiveness to social cues [32]. A
meta-analysis of 11 independent populations of patients
with ASD reported associations with rs7632287,
rs237887, rs2268491 and rs2254298 [33].
The focus of this review is on the newly emerging
field of OXTR epigenetics and socio-emotional func-
tioning in humans. Epigenetic mechanisms are
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reversible modifications occurring “above” the level of
the DNA sequence, which can influence gene expres-
sion [34]. The most widely investigated and under-
stood epigenetic mechanism is DNA methylation
(DNAm), which commonly involves the addition of
methyl groups to the cytosine and guanine dinucleo-
tides termed “CpG” dinucleotides in the DNA se-
quence. OXTR is of particular interest because, unlike
OXT, which has tight regional expression, OXTR is
expressed extensively through brain and body and can thus
control the final (rate-limiting) step in signal transmission.
Differential methylation of the OXTR has been associated
with changes in OXTR expression both in animals and in
humans.
In mouse models, OXTR DNAm patterns have been
correlated with differential OXTR expression in different
body tissues [35]. In different brain areas, differing
DNAm at specific CpG regions within the OXTR oc-
curred with differential expression of OXTR [36]. The
differential OXTR expression is considered to relate to a
diversity of animal social behaviours arising from the
limbic brain structures. Though animal and human
OXTR gene promoter brain regions differ, the inference
is that DNAm differences result in OXTR transcription
changes with impact on human social and emotional
behaviour.
In human samples, a region within the OXTR third in-
tron between regions encoding trans-membrane domains
6 and 7, has been shown to be hyper-methylated within
non-expressing tissues, but hypo-methylated in the uterine
myometrium at term, when OXT is up-regulated for the
birthing process [21]. Further work on OXTR has identi-
fied a region between the first exon and the first intron
(MT2 segment) that is linked to tissue specific expression
OXTR in peripheral blood mononuclear cells (PBMCs),
liver, and uterine myometrium (from non-pregnant and
term-pregnancies) [37]. Genetic variation may also influ-
ence patterns of DNAm within the gene [38–41] and thus
can have both combined and independent effects on gene
expression [42, 43]. However, lack of replication to date
requires cautious interpretation.
The purpose of this review by narrative synthesis is to
bring together the emerging evidence on OXTR DNAm
and human socio-emotional functioning. The diversity
of studies available in this new area of research currently
precludes meta-analytic presentation of findings. This
review provides a timely summary of a new field of re-
search around OXTR and socio-emotional behaviour,
with implications for future promotion of emotional
health in both population and clinical settings.
Method
A review of the literature was undertaken to identify all
published studies that investigated oxytocin receptor
gene (OXTR) DNAm in human social behaviour, with a
focus on social and/or emotional functioning. We defined
human social and emotional functioning as the experi-
ence, expression and management of emotions as well as
the ability to establish positive and rewarding relationships
with others [44]. This extends to relationships, response
to stress and social cognition with a basis in neurobiology,
which has become more available to research through
functional brain scanning.
Search strategy and inclusion criteria
Included studies were identified using review method-
ology, conducted across four primary search database
platforms: Web of Knowledge/Science, Scopus, Medline
and EMBASE and included papers through to May
2017. The search terms used were: ‘oxytocin gene’ or
‘oxytocin receptor gene’ and ‘epigenetics’ or ‘DNA
methylation’ and limited to studies involving humans
and those written in English. Four different searches
were completed with each search using terms: ‘oxytocin
gene’ or oxytocin ‘receptor gene’ and one of ‘epigenetics’
or ‘DNA methylation’. These four different term search
strategies were repeated from October 2013 to May
2017 on three separate occasions. This allowed for iden-
tification of new research as well as the confirmation of
those articles already located. There were no exclusions
based on participant age or study design. Studies which
measured OXTR DNAm in the context of oncology,
pregnancy or lactation were also excluded. The search
was not restricted to specific psychosocial terms; rather,
articles with a focus on emotional and social functioning
were identified by manual review from the full set meet-
ing criteria for epigenetic search terms. Manual identifi-
cation of studies was also employed by examining the
reference lists of original research articles retrieved, as
well as reviews published in this area. No new articles
were identified by this latter method that had not
already been retrieved from the original designated term
searches.
From all studies identified through the initial search,
titles and abstracts were examined to determine their
suitability for inclusion in the review. Titles often identi-
fied the article related to non-human studies, focused on
oncology/obstetrics, related to oxytocin or not to epi-
genetics. When uncertainty occurred, further investiga-
tion of the abstract clarified the exact contact of the
article. Studies included were original research articles
investigating epigenetic regulation of OXTR and its asso-
ciation with social or emotional behaviours in humans,
including social perception, mood problems (depression
and stress), behaviour problems (eating disorder and cal-
lousness) and rarer neurodevelopment disorders (autism).
No epigenetic studies were found where mechanisms
other than DNAm were considered.
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Results
Figure 1 presents a PRISMA flow diagram showing ini-
tial study identification and stepwise exclusions of ineli-
gible studies. A total 374 articles were initially identified
for review. Of these a total of 19 were eligible for inclu-
sion in the final review. Details of each are provided in
Table 1. Study populations varied widely in age, heritage
and from general population to clinical samples. Sample
sizes were variable and predominantly small though size
has been increasing in more recent research [45]. Most
studies focused on the “MT2 segment” (between Exon 1
and Intron 1), the region identified as functionally sig-
nificant in the initial gene expression studies (Fig. 2,
Area A) [21, 37, 46]. Increased DNAm of this region, in-
cluding the site − 934, has been linked to decreased
OXTR gene transcription in both PBMCs and brain [46].
No study has examined the extent to which DNAm in-
fluences gene expression in Exon 3, (Fig. 2, Area B).
Only one of the 19 studies directly examined the rela-
tionship between OXTR DNAm and gene expression
[46]. Two studies investigated a possible association be-
tween DNAm changes at the OXTR and subsequent
oxytocin neuropeptide synthesis [47, 48]. As DNAm
marks can be cell and tissue specific, it is important to
note that most studies have used DNA derived from
blood samples. One study each used buccal [49] and sal-
iva samples [38], the latter of which may contain buccal
epithelium and blood cells, including peripheral blood
mononuclear cells (PBMCs). A third study investigated a
small subset of brain tissue collected post-mortem [46].
Social perception
Jack et al. [50] and Puglia et al. [51] examined the associ-
ation between OXTR DNAm and brain activation using
fMRI brain scanning while participants completed social
perception tasks. The first involved visual animation
tasks with different social perceptions [50], while the
second used emotional face-matching tasks [47]. Both
studies involved healthy young adults and examined
OXTR DNAm in PBMCs, focusing on only one specific
CpG site (− 934), around the MT2 segment. In both
studies, results showed DNAm to be positively associ-
ated with brain activity in specific regions. These in-
cluded the temporal parietal junction and dorsal anterior
cingulate brain areas, regions associated with the face,
the amygdala and fusiform gyrus and insula involved in
emotion processing. Increased DNAm was also associ-
ated with decreased connectivity between the neural sys-
tems supporting social perception and decreased
functional coupling of the amygdala within regions asso-
ciated with affect appraisal and emotional regulation.
Social stress
Unternaehrer et al. [52] examined the possibility of dy-
namically changing levels of DNA methylation in re-
sponse to a social stress test within a longitudinal study
design. DNAm at two proximal regions of the OXTR
promoter was measured in whole venous blood over a
90-min interval, in 75 older individuals. In one of the re-
gions, an increase in DNAm at the majority of CpG sites
was found from pre-test to 10 min post-test. At both
OXTR regions DNAm decreased between 10 min
post-test and 90 min follow-up. The effect sizes ob-
served were small but significant. The investigators com-
pleted cell counts and controlled for these differences in
their analysis, also acknowledging that changes in dy-
namic cell composition could contribute to their results.
Anxiety disorders
Two studies examining OXTR DNAm in the exon 3 re-
gion from blood and anxiety disorders were identified
[53, 54]. Ziegler et al., investigated 110 adults with social
anxiety compared to 110 healthy controls and noted re-
duced DNAm at only one of twelve CpG OXTR exon 3
sites on psychological, cortisol response and fMRI mea-
sures [54]. When average DNAm was considered across
all twelve CpG sites, reduced methylation was also ob-
served compared to controls. No difference between so-
cially anxious patients and controls was noted when the
rs53576 genotype was investigated. Furthermore, Cappi
et al., studied 73 adults with obsessive compulsive dis-
order (OCD) compared to 31 healthy controls and found
increased DNAm at two of nine CpG OXTR sites in
OCD adults compared to controls [53]. DNAm was
positively correlated with OCD severity. In contrast, an
Fig. 1 PRISMA Flow Diagram
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Table 1 Studies investigating the association between DNA methylation (DNAm) of the oxytocin receptor (OXTR) gene and human
behaviour (by year of publication)
Study Characteristics Main Measure Tissue OXTR region &
measurement
Methylation Association Adjustment
Gregory et
al. (2009)
[46]
(i). 119 Autistic Spectrum
Disorder (ASD) probands
(78% male) & families.
(ii). 20 ASD (50% male) & 20
controls. (iii). 16 brain
samples in 8 ASD (75% male)
& 8 controls (Caucasian US)
ASD (DSM-IV criteria)
& ADI-R
PMCS &
brain
tissue
(temporal
cortex)
2 regions:
(i) exons 1, 2 &
3 incl. MT2 a
(ii). 3rd intron
No SNPs
DNAm Specific
sequencing
i) ASD Family study: ↑ DNAm
5/22 CpG sites (− 860, − 901,
− 924, − 934 & -959) in
region (i) with significant
associations at − 860 & - 934
in males & -959 in females
ii) ASD vs controls: ↑DNAm 3
CpG sites (− 860, − 934, −
959). iii) Brain samples: ↑
DNAm 4 CpG sites (− 860, −
901, − 924, − 934)
iv) ↓ Gene expression: PCR
↓mRNA in ASD male brains
Matched: age &
gender.
Jack et al.
(2012) [42]
42 healthy adults (55% male)
18–30 yrs. Inclusion: normal
vision & no previous
psychiatry (67%Caucasian
US)
fMRI brain scan of
during visual
perception animation
tasks.
PMCS - 934 single site
No SNPs
Pyrosequencing
↑ DNAm site −934
associated with ↑fMRI
activity in temporo-parietal
junction incl. dACC during
tasks.
No racial or gender
differences
Unternaehr-
er et al.
(2012) [48]
76 adults (43% male) 61–
67 yrs. (Caucasian Germany).
TSST 3× whole
venous
blood:
before
TSST, 10 &
90 mins
2 regions in
exon 3: OXTR1
& OXTR2
No SNPs
Sequenom
EpiTYPER
↑DNAm 7/8 CpG sites
OXTR1: pre to 10 mins post-
test & ↓DNAm from 10 mins
to 90 mins post-test.
↓DNAm trend 2/27 CPG sites
OXTR2: 10 to 90 mins. Post-
test.
Blood cell counts &
batch effects. No
sex differences.
Multilevel models
Cecil et al.
(2014) [53]
84 youth with conduct
disorderb (no gender ratio),
(UK).
High Callous
Unemotional (CU)
traits maternal
assessed at 13 yrs
PMCS in
cord
blood, 7 &
9 years
12 probes
across gene.
SNPs:4 CU
focus
Illumina array
450 Kc
↑DNAm 3/12 probes on
exon 2 in cord blood with ↑
CU in low internalising
problems group & with
↑parental risk exposures
(prenatal & late-childhood.
SNPs rs2301261, rs237915,
rs4564970, rs4686302
NSd with DNAm, CU or
internalising groups.
Gender stratified
analysis
(internalising
problems)
Dadds et al.
(2014) [49]
98 male; 4–16 yrs.: conduct
disorder or Oppositional
Defiant Disorder (ODD)
Exclusion: ASD, neurological
/physical illness, ↓IQ.
(Australia).
i).ODD /Conduct
Disorder assessmente
ii). CU traitsf
Blood 11 probes:
exon 1 - intron
1.
No SNPs
Sequenom
MassARRAY
Children 9-16 yrs., ↑ DNAm
associated with ↑ CU traits.
Examining the 6 individual
CpG sites, these findings
were predominantly with
CpG 5
Subset 37 youth ↑DNAm
associated with ↓ circulating
OXT protein levels, in older
children only.
Covariates tested.
Kim et al.
(2014) [39]
51 females, 18 + yrs. (15
Anorexia Nervosa (AN); 36
healthy controls (South
Korea) Exclusion: ASD,
psychosis & substance use
disorder.
SCID (DSM-IV) & EDE-
Q, BMI, AQ (ASD
traits), DBI & STAI.
Buccal 48 probes:
exon 1-intron 1.
No SNPs
DNAm specific
sequencing
↑DNAm 5/48 CpG sites &
averaged across region
associated with AN.
↓BMI correlated ↑DNAm at
5/48 CpG sites
ASD traits did not associate
with DNAm
Age, BMI & clinical
variables (ASD,
anxiety &
depression)
Bell et al.
(2015) [34]
269 female postnatal
depression (131 antenatal
depression); 276 matched
controls (135 antenatal
depression). 2/3 s: 25–34 yrs.
(Caucasian UK)
EDPS: antenatal &
postnatal
Whole
antenatal
blood
- 934 single site
SNPs rs53576 &
rs2254298
Pyrosequencing
↑DNAm for females with
postnatal depression only in
rs53576 GG
Matched: age,
parity, depress-ion.
Adjusted Models:
psychosocial
covariates.
Chagnon et
al. (2015)
[33]
43 females > 65 yrs. (18 prev.
Anxiety & MDD, 1 with MDD;
24 controls. Excluded:
Anxiety & MDD (DSM-
IVR)g
Saliva 9 probes in 2
regions: exon 3.
SNPs: rs53576
Pyrosequencing
No difference between
groups overall.
↑DNAm (× 2) for females
with anxiety/depression who
Matched: no
details
Maud et al. BMC Psychiatry  (2018) 18:154 Page 5 of 13
Table 1 Studies investigating the association between DNA methylation (DNAm) of the oxytocin receptor (OXTR) gene and human
behaviour (by year of publication) (Continued)
Study Characteristics Main Measure Tissue OXTR region &
measurement
Methylation Association Adjustment
psychosis, schizophrenia or
MMSE score < 22. (Canada).
were rs53576 AA when
averaged across region 1 (4
probes) and for 1/5 CpG
sites of region 2.
Puglia et al.
(2015) [47]
98 healthy adults, (43% male)
18–30 yrs.: normal vision.
(Caucasian, US)
fMRI brain scan
during emotional face
matching task
PMCS - 934 single site
No SNPs
Pyrosequencing
↑ DNAm associated with
fMRI responses: ↑ face &
emotion processing areas
(amygdala, fusiform & insula)
& ↓ connectivity between
social perception systems &
↓ coupling amygdala &
emotional regulation
regions.
Gender stratified
analysis. Age: NS
Reiner et al.
(2015) [35]
85 premenopausal female
adults (43 depressed & 42
controls), aged 19–52 yrs.
Excluded: psychosis, medical,
personality, eating &
substance use disorders.
(Caucasian Germany).
MDD (SCID-DSMIV) PMCS Mean DNAm:
exon 1(36
sites); exon 2(6
sites)
SNP: rs53576
DNAm Specific
sequencing
(ESME software)
↓DNAm in exon I (not exon
2) in depressed females.
↓DNAm in depressed
females rs53576 GG > AG/AA
but in healthy controls
↑DNAm in GG > AG/AA.
↓DNAm in exon 2 associated
with rs53576 GG & not
depression
Matched: age and
education. Mixed
models: age,
alcohol, smoking,
BMI antidepressant
use.
Unternaehr-
er et al.
(2015) [52]
85 university students with
maternal care: low (45) and
high (40) (79% female) aged
19–66 (median 24).
(Caucasian, Switzerland)
PBI (maternal care)
when < 16 years:
retrospective
assessment
Whole
blood
2 regions in
exon 3 (OXTRTS1
& OXTRTS2). (35
CpG units) No
SNPs
Sequenom
EpiTYPER
↑ DNAm in low versus high
maternal care in OXTRTS2
↓DNAm in males compared
to females independent of
maternal care in OXTRTS2.
Adjusted: age,
gender, batch
effects. Mixed
model analysis: cell
count, BMI &
depression
considered.
Ziegler et
al. (2015)
[51]
220 adults: 110 un-
medicated social anxiety (76
female & 34 male); 110 con-
trols (77 female & 33 male)
Excluded: medical, psychosis
& substance use disorders.
(Caucasian Germany)
Psychological: SIAS,
SPS; cortisol response
to TSST, fMRI of
amygdala during
social anxiety word
task.
Whole
blood
Region in exon
3 with 12 CpG
sites.
SNP: rs53576
DNAm Specific
sequencing
(ESME software)
↓DNAm at 1/12 CpG site
with psychological measures,
cortisol response & fMRI.
↓average DNAm across all 12
CpG sites in social anxiety
patients compared to
controls.
↓average DNAm & at 7/12
CPG sites for rs53576 AA/
AG > GG.
Matched: age and
sex
Cappi et al.
(2016) [40]
73 adults: 42 OCD (9 CBT or
fluoxetine /33 treatment
naïve); 31 controls: 18–65 yrs.
Excluded: psychosis, suicide
risk, prev. Head injury,
medical & substance use
disorders (Brazil)
OCD(DSMIV): Y-BOCS
score≥ 16 (obsessions
& compulsions) or ≥
10 (obsessions or
compulsions), BDI,
BAI, YGTTS.
Peripheral
blood
leucocyte
≤2 weeks
treatment
2 regions exon
3:OXTR 1 (4
CpG sites) &
OXTR 2 (5 CpG
sites).
No SNPs
Pyrosequencing
↑DNAm at 2/9 CpG sites in
OCD > controls.
↑DNAm correlated with
↑OCD severity
↑DNAm at 8/9 CpG sites
with ↓BDI score.
No difference DNAm
between 33 treatment naïve
or 9 fluoxetine/CBT.
No DNAm correlation
between OCD & tics.
Examined age, sex,
education, BDI
score, BAI score,
tics, YBOCS score
Elagoz
Yuksel et al.
(2016) [41]
66 children: 27 ASD (23 male
& 4 female); 39 controls (6
female & 33 male), 22–
94 months. Excluded:
medication, ↓development,
neuro-degenerative, medical
& psychiatric
disorders(Turkey)
ASD (DSMIV-TR) CARS
(≥30 for ASD).
Peripheral
blood
4 regions: exon
1 – exon 3 (MT
1–4).
No SNPs
DNAm Specific
sequencing
↓DNAm in 2/4 regions: MT1
& MT3 in ASD > controls.
MT1 site (exon 1) DNAm %:
44.4% ASD & 71.8% healthy
controls
MT3 site (intron 1, exon 2,
intron 2) DNAm %: 29.6%
ASD & 61.5% healthy
controls.
Matched: age &
gender.
Kimmel et
al. (2016)
[43]
51 females postnatal
depression: average 30.6 yrs.
(70% Caucasian). Previous
MDD (DSMIV)≤ 1st
month >birth.
Whole
blood T3h
18 CpGs sites
SNP: rs53576
↓DNAm 1/18 CpG site in
female postnatal depression.
rs53576 NS
Adjusted cell
proportions.
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inverse correlation was found between DNAm at eight
of the nine sites for depressive scores in OCD adults.
This could suggest that social anxiety and OCD sit on
different dimensions, as is now the case in the latest iter-
ation of the DSM-5 in which OCD is considered to be
related to ASD and rigidity of thinking where as social
anxiety disorder is considered a form of mood disorder.
Depression
Reiner et al. compared OXTR DNAm in PBMCs between
depressed pre-menopausal women and non-depressed
age-matched controls [40]. Three fragments across exons
1 and 2 of OXTR (A, B and C) were measured. A decrease
in DNAm of the exon 1 fragment A, (Fig. 2) was observed
in depressed compared to non-depressed women. A
specific OXTR SNP rs53576 with a G to A allele change,
known to be associated with reduced pro-sociality and de-
creased empathy, was also investigated [29]. This SNP
moderated the association between DNAm of exon 1 and
depression status and was found to be independently asso-
ciated with exon 2 methylation levels. Depressed individ-
uals with the A allele had increased mean DNAm
compared to those homozygous for the G allele but
healthy controls had the opposite result [40].
A further study by Chagnon et al. compared 19 de-
pressed older women (all but one of whom also had anx-
iety) with 24 controls both in terms of saliva DNAm,
average methylation across exon 3, and with regard to
rs53576 [38]. There were no differences in overall
DNAm between groups; however, depressed women
Table 1 Studies investigating the association between DNA methylation (DNAm) of the oxytocin receptor (OXTR) gene and human
behaviour (by year of publication) (Continued)
Study Characteristics Main Measure Tissue OXTR region &
measurement
Methylation Association Adjustment
mood disorder (66% MDD,
33% Bipolar Disorder) (US)
Illumina array
450 K (Brain
Cloud tool)
Rubin et al.
(2016) [50]
242 adults: 167 with
psychosis (affective/bipolar
disorder & non-affective/
schizophrenia (92 female &
75 male); 75 healthy controls
(38 female & 37 male). Ex-
cluded: previous head injury,
↓ reading, medical & sub-
stance use disorders (US)
Psychosis (DSMIV);
Penn Emotional
Recognition Task;
fMRI during facial
recognition task (79%
sample)
Whole
blood
A single CpG
site (−934)
No SNPs
Pyrosequencing
↑DNAm schizophrenia >
bipolar disorder
↑DNAm psychotic females
>males
↑DNAm with ↓emotional
recognition in females &
controls > males.
↑DNAm with ↓ brain
volumes: temporal-limbic
and prefrontal regions (social
cognition) in healthy con-
trols & schizophrenia
females.
Plasma OXT levels and
DNAm NS in psychotic/
controls Gender differences
in plasma OXT & DNAm: (−)
males & (+) for females.
Age, race,
intracranial brain
volume
Sex stratified.
Smearman
et al. (2016)
[36]
393 adults (70.7% female)
18–77 yrs.: childhood abuse
& current anxiety/depression
(African American, US).
CTQ, HAMA, BDI
Traumatic Events
Inventory
Whole
blood
18 CpG sites
(before exon 1-
intron 3)
SNPs 44
Illumina array
450 K
↑ DNAm associated
childhood abuse at 2/18
CpG sites but NS. DNAm not
a mediator of psychiatric
symptoms. 44 proximal SNPs:
68% associated DNAm of
nearby CPG sites.
Age, sex & cell
type
Unternaehr-
er et al.
(2016) [44]
39 infants with mothers
mean age 31.9 yrs. (no sex
ratio)(Switzerland)
Pregnant mother:
EDPS, TICS-K, ILE, sal-
iva cortisol in T2i, T3h.
Cord
blood
13 CpG sites
(exon 3)
No SNPs
Sequenom
EpiTYPER
↓ DNAm associated with ILE,
EDPS, T2 maternal cortisol
(AUCg).
Batch effects,
demographics,
pregnancy & births.
Rijlaarsdam
et al. (2017)
[45]
743 children (51% male)
≤6 years yrs. (Netherlands)
ASD 6 yrs. with
parental ratings: SRS.
Maternal prenatal
stress
Cord
blood
3 CpG sites
across gene.
SNP: rs53576
Illumina array
450 K
DNAm & prenatal maternal
stress or ASD: NS
↑DNAm associated ↓social
communication: rs53576 GG
Child sex, age, cell
type, maternal
smoking &
technical array.
a. MT2 segment is a genomic region on OXTR identified by Kusui, 2001; b. Diagnostic Interview Schedule for Children, Adolescents & Parents; c. 450 K: Illumina
Human Methylation 450 Bead Chip array (Illumina, USA); d. Not Significant; e. Antisocial Process Screening Device/ASPD & pro-social subscale of Strengths &
Difficulties/ PSSSDQ; f. Youth with early onset & persistent conduct problems assessed by Strengths & Difficulties Questionnaire ‘Conduct problem’ subscale; g.
Diagnostic Interview Schedule and Composite International Diagnostic Interview for anxiety and depressive disorders; h. pregnancy second Trimester; i. pregnancy
third Trimester
Maud et al. BMC Psychiatry  (2018) 18:154 Page 7 of 13
homozygous for the A allele of rs53576 showed a signifi-
cant increase in DNAm compared to controls. Different
genotypes may have an independent impact on DNAm,
which could contribute to these differing results [23].
The age of the population, including physiological states
such as weight loss, hormonal and mood influences and
the independent effect of the genotype itself may vari-
ously account for the different results.
Perinatal disorders
Unternaehrer et al. also investigated OXTR DNAm in
the cord blood of 39 infants born to mothers who had
completed psychological testing and saliva cortisol test-
ing during the second and third trimesters of their preg-
nancies [55]. Cord blood is the first available tissue
following birth, which allows for the exclusion of postna-
tal factors impacting on the DNAm process. In their
final testing 7 OXTR CpG units, including 13 sites, were
investigated for DNAm with varying results. Reduced
DNAm in the cord blood of the infants was associated
with the total number of stressful life events in the two
years prior to the second trimester, but not the strain
caused by these events. Likewise, reduced DNAm in in-
fant cord blood was associated with maternal depressive
symptoms in the second trimester and certain elevated
salivary cortisol level measurements from the second
and third trimesters. The investigators used specific
mixed modelling and batch effects analysis to obtain
more reliable results.
Using data from the Avon Longitudinal Study of Par-
ents and Children (ALSPAC), Bell et al. measured OXTR
DNAm in whole blood, as well as two OXTR SNPs
rs53576 and rs2254298 and investigated associations
with perinatal depressive symptoms [39]. While no main
effects were observed, overall a significant DNAm by
genotype interaction was associated with the risk of
postnatal depression. For women who were rs53576 GG
homozygous alleles, there was a positive correlation be-
tween OXTR DNAm and depressive symptoms postpar-
tum. This finding is in contrast to the other studies of
depression where associations were found between
OXTR DNAm and depression risk for individuals with
the rs53576 A allele [38, 40], possibly accounted for by
hormonal differences compared to mood disorders at
differing times in the life-cycle.
Additionally, Kimmel et al., investigated 51 women
with postnatal depression considering the complex hor-
monal impact, including estradiol on OXTR methylation
[56]. Though 18 OXTR loci were investigated, only one
demonstrated significantly decreased DNAm in the
whole blood samples of the cohort and no significant
rs53576 analysis was noted.
Maternal care
In a sample of 85 university students, Unternaehrer et
al. compared OXTR DNAm across groups who retro-
spectively reported low or high maternal care [57]. No
SNP genotypes were examined. Students reporting a his-
tory of low maternal care had increased DNAm at one
of 23 CpG units examined. In addition to the retrospect-
ive self-reporting of early maternal care, confounding
from other factors is an obvious limitation given the
large time gap between childhood and the period when
DNAm was measured. Smearman et al. likewise exam-
ined association between OXTR and retrospective
reporting of childhood abuse and adult psychiatric
symptoms (anxiety and depression) [41]. This study,
with 393 African American participants, involved a com-
prehensive investigation of 18 CpG sites across the
OXTR gene, as well as 44 OXTR SNPs. Of the 44 SNPs
a b
Fig. 2 Oxytocin Receptor Gene (OXTR Chr:3 p25)
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examined, 68% were associated with proximal DNAm
levels. Non-significant trends were observed between
childhood abuse and higher DNAm at two CpG sites in
exon 3, as well as an interaction between childhood
abuse and DNAm to predict adult psychopathology. Six
SNPs of interest were also shown to interact with child-
hood abuse in determining risk for psychiatric symp-
toms, independently of DNAm levels.
Anorexia nervosa
Kim et al. studied Korean patients with Anorexia Ner-
vosa and investigated DNAm of the OXTR MT2 region
in buccal samples [49]. They found increased DNAm in
15 clinical patients compared to 36 University recruited
controls. The extent of DNAm negatively correlated
with illness severity (BMI) and eating disorder psycho-
pathology. As no longitudinal analysis was undertaken,
the temporal relationship between increased DNAm and
onset of Anorexia Nervosa could not be established. It
remains unclear whether changes in OXTR DNAm pat-
terns precede or are the consequence of the disease.
Callous unemotional
Two studies measured peripheral blood OXTR DNAm
in children and adolescents with conduct problems, with
a particular focus on Callous Unemotional (CU) traits
[47, 58]. As part of the ALSPAC study, Cecil and col-
leagues measured OXTR DNAm at birth in a subset of
84 boys and girls and found a positive association with
CU traits in later childhood (7–9 years) [58]. There was
no difference in association when the groups were strati-
fied by internalising problems. In contrast, Dadds et al.
focused on males only (n = 98) and found no association
between OXTR promoter DNAm and CU traits overall,
but some evidence that increased DNAm levels at one
particular CpG site were associated with increased CU
traits in older youth (aged 9–16 years) [47]. In a small
subset of this cohort (n = 37), authors reported increased
DNAm and lower oxytocin protein levels in the blood of
older children (aged 9–16 years) but caution against over
interpretation due to power limitations. Additionally, 9
OXTR SNPs were examined. Only rs1042778 replicated
an association with high CU traits across sexes and be-
tween childhood versus adolescent age groups within 2
separated geographical groups [59].
Autism Spectrum disorder
While numerous studies have investigated the role of
OXTR genetic variations in ASD, only three to date have
examined OXTR DNAm [45, 46, 60]. The first study by
Gregory et al., reported findings from three separate
analyses [46]. The first included screening of 119 ASD
pro-bands and their families to identify DNAm differ-
ences at OXTR sites in PBMCs, focusing on the area in
the promoter region around the MT2 site. Increased
DNAm was noted in ASD pro-bands compared to
healthy family members. This analysis was complemen-
ted by a small ASD case-control study (n = 40) focusing
on the same OXTR sites identified in their initial analysis
demonstrating similar results. The authors also used
eight samples from a brain bank of patients with autism
and eight controls and compared DNAm levels in
PBMCs with these brain temporal cortical samples, find-
ing both had increased DNAm. This group further exam-
ined brain OXTR DNAm with gene expression in samples
of temporal cortex from 4 ASD pro-bands (3 males and 1
female), matched with controls. For the 3 males only,
OXTR expression was reduced by 20% compared to con-
trols. Results from these studies suggest remarkable
consistency across the different tissues (PBMCs and brain
temporal cortex). They support a relationship between in-
creased DNAm and decreased OXTR gene expression,
with the suggestion that there may be sex-specific effects
(findings in males and not female, in a small cohort).
A second study by Elagoz Yuksel et al., found the op-
posite effect in children with ASD, with decreased
DNAm in two of four areas of the OXTR including MT1
(exon 1) and MT3 (intron 1, exon 2 and intron 2) when
peripheral blood samples of 27 children with ASD were
compared to 39 healthy controls [60]. Both ASD and
healthy control children were predominantly male. It is
important to note that these investigators did not find
any significant associations within the MT2 area, which
had been previously been implicated by Gregory et al.
[46] and Kusui et al. [37].
A third study by Rijlaarsdam et al., investigated OXTR
DNAm associated with the specific SNP rs 53,576 in
cord blood sampled at birth from children later diag-
nosed with autistic traits at six years’ of age [45]. In-
creased DNAm was found in those children with
rs53576 G-allele homozygous who demonstrated higher
social problem scores. Prenatal maternal stress exposure
was also investigated but not found to be associated with
OXTR DNAm in this sample of children.
Psychotic disorders
Rubin et al., investigated the whole blood samples of 167
patients with both affective and non-affective psychoses
compared to 75 healthy controls [48]. A further compo-
nent of this study was fMRI of a subsample of this co-
hort during a facial emotional recognition test. OXTR
DNAm was examined in one specific CpG site (− 934),
around MT2 segment, similar to studies by Jack et al.
[50] and Puglia et al. [51]. Findings point to increased
DNAm when patients with non-affective psychosis were
compared to those with affective psychosis. Gender spe-
cific effects were noted with increased DNAm in females
with psychosis compared with males, increased DNAm
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associated with poorer emotional recognition in females
and controls than males, and increased DNAm associ-
ated with smaller brain volumes in areas related to social
cognition (temporal-limbic and pre-frontal regions) in
females with non-affective psychosis and healthy control
females. This study also measured oxytocin protein
levels but found no significant association with these
and OXTR DNAm in the psychotic or control group un-
like the study by Dadd et al., when investigating callous
unemotional children [47]. Gender differences were
noted when plasma oxytocin levels and DNAm were in-
vestigated with a negative association for males (p =
0.04) and a positive association for females (p = 0.03).
Discussion
The role of OXTR DNAm in human social and emo-
tional functioning is a relatively new area of investiga-
tion. There are currently few studies in the field and
methods and findings are highly variable, precluding
firm conclusions about the role of OXTR DNAm. How-
ever, within this context, several non-replicated associa-
tions between OXTR DNAm and outcomes in various
domains are emerging in the literature. These include
positive associations between OXTR DNAm and
callous-unemotional traits in youth [47, 58], social cog-
nitive deficits in ASD [45, 46], rigid thinking in anorexia
nervosa [49], affect regulation problems [41, 57] and
mood deficits [38–40] as well as limbic regions linked
with facial and emotional recognition [48, 50, 51]. In
contrast, reduced OXTR DNAm has been associated
within indicators of perinatal stress [55], postnatal de-
pression [56], social anxiety [53] and autism in children
[60].
Taken together, findings suggest a role for increased
OXTR DNAm (which may indicate reduced receptor ex-
pression) in general impairments in social, cognitive and
emotional functioning, and decreased OXTR DNAm
(which may indicate increased receptor expression) in
specific patterns of impairment related to mood and
anxiety disorders (but not all). However, patterns of as-
sociation both within and across outcomes are difficult
to clearly demarcate, and most likely reflect the broad
range of differences that exist between studies at this
early point in the development of the field. For example,
reported associations for mood disorders are in both dir-
ection, which may reflect striking differences between
studies, including type of mood disorder under investi-
gation, epigenome regions studied, underlying variation
in genotypic and hormonal factors [39, 56] as well as the
effect of aging [38].
Furthermore, exceedingly little is known about the
functional implications of OXTR DNAm in humans.
Only one study has reported a relationship between in-
creased OXTR DNAm and reduced OXTR expression
[46]. Another has reported a relationship between mean
OXTR DNAm across eleven probes (spanning exon 1 to
intron 1) and circulating oxytocin protein levels; how-
ever, this was not replicated in another study examining
a single CpG site (− 934) in intron 1 [48]. This is an im-
portant area for future research. Genetic association
findings are equally non-conclusive with results differing
considerably across the studies. Lack of reproducibility is
common in genetic association studies and likely reflects
small sample sizes of unknown representation with
underpowering. Future progress on genetic influences
will depend on access to larger samples and benefit by a
shift from its current focus on candidate SNPs to
genome-wide analysis (GWAS). Furthermore, replication
opportunities are essential for establishing the credibility
of reported genetic associations. Earliest canvassing of
these opportunities would permit optimised alignment
of research samples and instrumentation.
A further driver of heterogeneity of DNAm findings is
choice of tissue for analysis. Studies in humans are lim-
ited to peripheral tissue collections i.e. buccal, blood or
saliva. The common embryological origin of brain and
buccal cells suggests that these two cell types may have
more in common than blood cells, and that using buccal
cells as a peripheral biomarker might provide a closer
approximation to central brain processes, relative to
other cell types [61]. At minimum, the tissue specific na-
ture of many epigenetic processes is likely to be an im-
portant contributing factor. The different methods of
analysis of OXTR DNAm from individual probe methy-
lation to EWAS analysis reflect the challenges of cost, in
a new area of investigation which further complicate re-
sult comparisons.
From a statistical methods perspective, the majority of
studies have investigated methylation at numerous indi-
vidual CpG sites [38, 40, 41, 45, 46, 49, 52–55, 57, 58],
but only a few studies have considered adjustment for
multiple comparisons in their analysis, [41, 47–49, 53,
55, 56], to reduce the risk of false positive findings (type
1 errors). This is particularly problematic for studies
which have investigated a large number of gene regions
and CpG sites. It thus remains possible that at least
some of the findings shown here are chance associations,
and replication in an independent sample is crucial. On
the other hand, some of the studies have used factor
analysis to reduce the number of CpG sites and thus
tests [40, 45, 47, 58]. The downside of these studies is
that factor analysis is a data driven process and does not
necessarily make biological sense. Further, conclusions
cannot be drawn about the impact of DNA methylation
at individual CpGs.
Longitudinal cohort studies beginning in the perinatal
period provide the optimal opportunity to study humans
at crucial time points during life. This informs knowledge
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as to how epigenetics contributes to the changing pheno-
type. Ng et al. identified that in thirty-four life course stud-
ies related to the epigenetic mechanism of DNAm, only
four studies included information taken from more than
1-time point. Of these four, one study involved epigenetic
changes over a relatively short time period (28–180 days)
[62]. The Avon Longitudinal study of Parents and Children
(ALSPAC) has collected serial samples across the life-span
from individual participants providing the gold standard in
longitudinal cohort studies for epigenetic analysis [63].
Longitudinal studies which collect biomarkers, at multiple
time-points, starting in the perinatal period for epigenetic
investigation are unique as an assessment of the changing
life-course phenotype. Cross-sectional analyses of epigen-
etic data lack utility in attempting to understand develop-
mental change or causation direction in epigenetic
epidemiology [64].
Conclusion
This narrative literature review examines findings from
nineteen papers, which have investigated OXTR DNAm
associated with social and emotional functioning in
humans. The broad and heterogeneous nature of these
studies preclude definitive conclusions. This is typical of
a new field of research where the study diversity in de-
sign, methodology, phenotype and outcome make mean-
ingful conclusions challenging.
Despite these considerable limitations, emerging evi-
dence points to increased OXTR DNAm in general im-
pairments of social, cognitive and emotional functioning,
and decreased OXTR DNAm in specific patterns of im-
pairment related to mood and anxiety disorders (but not
in all). These higher-level patterns are speculative at best
in this stage of the field’s early development. The essen-
tial “next step” is to establish with greater certainty the
functional relationship between OXTR DNAm and ac-
tual OXTR gene expression. Related to this is greater
clarity about potential differences in OXTR DNAm
across peripheral tissues currently collected in human
studies in relation to central brain tissue OXTR pro-
cesses. If these fundamentals can be established, progress
would be facilitated by increased homogeneity in study
design, including phenotypic definition and measure-
ment. This includes greater investment in high quality
measurement, such as micro-coding of social interaction
using gold-standard protocols, for example, human at-
tachment behaviour, within observational designs [65].
Future progress would also be enhanced by greater in-
vestment in embedded DNAm studies within longitu-
dinal designs that enable temporal ordering of relationships
with biological collections at multiple time-points. The De-
velopmental Origins of Health and Disease (DOHaD) para-
digm emphasises the centrality of exposures within the first
1000 days from conception, however sensitive periods may
occur both before and after birth [66]. Longitudinal cohort
studies, particularly those with mature cohorts that cross
more than one generation, will provide important future
opportunities for investigating change over time. Of par-
ticular interest are longstanding cohorts prospectively
tracking offspring development, given their unique oppor-
tunity to explore effects beyond a single generation, to
those that transmit to subsequent generations.
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